CLASS I Drug recall · Reported 12 Feb 2014 · FDA Enforcement Report

50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL) recalled

Baxter Healthcare is recalling 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), Baxter Healthcare Corp, distributed nationwide in the US. The recall was initiated on 18 Nov 2013 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesG105197, Exp. 02/14
NDC0338-1047, 0338-1049, 0338-1051
Quantity recalled49,932 glass containers

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1057-2014
FDA event ID
66880
Recalling firm
Baxter Healthcare, Deerfield, IL
Manufacturer
Baxter Healthcare Company
Classification
Class I
Status
Terminated
Recall initiated
18 Nov 2013
FDA classified
31 Jan 2014
Reported
12 Feb 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

18 Nov 2013Recall initiated by company
31 Jan 2014Classified by FDA+74 days
12 Feb 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.

Product as listed by the FDA

50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), 250 mL glass containers, Baxter Healthcare Corp., Deerfield, IL --- NDC 0338-1049-02

Where it was distributed

Nationwide, Saudi Arabia and Colombia

Nationwide

Questions about this recall

Is 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), Baxter Healthcare Corp recalled?

Yes. Baxter Healthcare recalled 50 mg Nitroglycerin in 5% Dextrose Injection (200 mcg/mL), Baxter Healthcare Corp on 18 Nov 2013. The recall is Class I and its status is Terminated. Recall number D-1057-2014.

Why was it recalled?

Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.

Which lots are affected?

G105197, Exp. 02/14

Where was it sold?

Nationwide, Saudi Arabia and Colombia

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 564

Other Nitroglycerin recalls

All 6